Haemonetics (HAE) Other Non-Current Assets (2010 - 2026)

Haemonetics has reported Other Non-Current Assets for 17 years, with the latest figure at $141.7 million in Q1 2026.

• For the quarter ending Q1 2026, Other Non-Current Assets fell 13.63% year-over-year to $141.7 million; the trailing twelve-month figure through Mar 2026 stood at $141.7 million (down 13.63% YoY), and the FY2026 full-year result was $141.7 million, down 13.63% from the prior year.
• Other Non-Current Assets for Q1 2026 stood at $141.7 million, down from $216.1 million in the prior quarter.
• The five-year high for Other Non-Current Assets was $216.1 million in Q4 2025, with the low at $63.2 million in Q2 2022.
• Average Other Non-Current Assets over 5 years is $131.8 million, with a median of $131.9 million recorded in 2023.
• Year-over-year, Other Non-Current Assets jumped 69.25% in 2023 and fell 13.63% in 2026.
• Tracing HAE's Other Non-Current Assets over 5 years: stood at $103.3 million in 2022, then increased by 23.39% to $127.4 million in 2023, then climbed by 25.87% to $160.4 million in 2024, then soared by 34.71% to $216.1 million in 2025, then slumped by 34.41% to $141.7 million in 2026.
• The last three Other Non-Current Assets figures came in at $141.7 million (Q1 2026), $216.1 million (Q4 2025), and $208.0 million (Q3 2025), per Business Quant data.

Peer Comparison